BY THE NUMBERS.
WHERE IT LANDED.
HOW FULL THE BUS GOT.
TICKET CLASSES.
Avience Biomedicals is an SME IPO, listed on NSE SME. The issue has listed with a price band of ₹208 and a lot size of 600 shares. It was open from 18 Jun 2026 to 22 Jun 2026, with listing completed on 25 Jun 2026. All figures are indicative and reflect the issue as it stood; the official Red Herring Prospectus (RHP) remains the record.
COMMON QUESTIONS.
What is the Avience Biomedicals IPO price band?+
The indicative price band is ₹208 per share. The binding terms are the ones in the Red Herring Prospectus (RHP).
What is the lot size of the Avience Biomedicals IPO?+
One lot is 600 shares. At the upper band of ₹208, one lot works out to ₹1,24,800.
When does the Avience Biomedicals IPO open and close?+
The issue opened on 18 Jun 2026 and closed on 22 Jun 2026. Dates can move — the registrar and the exchange notices are the record.
When is the Avience Biomedicals IPO allotment?+
Allotment is scheduled for 23 Jun 2026. The basis of allotment is published by the registrar to the issue. BuyUnlistedShares does not accept, process or track IPO applications.
When did Avience Biomedicals list?+
Listing took place on 25 Jun 2026 on NSE SME.
Where will Avience Biomedicals be listed?+
Avience Biomedicals is listed on NSE SME. It is an SME issue, so it trades on the SME platform.
How large is the Avience Biomedicals IPO?+
The issue size is ₹30.24 Cr. Figures are indicative and subject to the RHP.
How was the Avience Biomedicals IPO subscribed?+
The issue was subscribed 385.32× overall. By category: qib 196.77×, nii 597.23×, retail 401.36×. Subscription figures are as reported by the exchanges.
At what price did Avience Biomedicals list?+
Avience Biomedicals listed at ₹395, +90% against the issue price.
What is the P/E ratio of the Avience Biomedicals IPO?+
The P/E ratio on file for this issue is 11.59. A reported ratio is not a view on value.